About
Genetic Screening for Ideal Treatments
Areas of Focus
Categories
DiagnosticsGenetics & GenomicsBiotech
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
1,193
By Phase
NA: 1
By Status
COMPLETED: 6TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04770922Lead Sponsor
Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
N/ACompleted
80 participants
Started: Feb 23, 2021 · Completed: Nov 10, 2021
NCT04580589Lead Sponsor
DOAC ADRs Retrospective Study on Genetic Variations
N/ACompleted
210 participants
Started: Feb 1, 2021 · Completed: Oct 31, 2022
NCT04702113Lead Sponsor
Evaluating Pharmacogenomic Variants for Cardiology Therapeutics
NACompleted
300 participants
Started: Dec 3, 2020 · Completed: Jul 27, 2023
NCT04580602Lead Sponsor
Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects
N/ACompleted
200 participants
Started: Oct 7, 2020 · Completed: Jun 9, 2022
NCT04597593Lead Sponsor
Association Between Genetic Variant Scores and DOACs (DARES2)
N/ACompleted
200 participants
Started: Oct 7, 2020 · Completed: Dec 30, 2022
Locations (1)
Headquarters
San Jose, CA, United States
Map
Loading map...